LOGIN
User Name:
Password:
Remember me   Forgot password?

Spectrum Pharmaceuticals, Inc. (SPPI)

Health Care
Biotechnology

Rating:
Rating Since: 08/05/2011
Prior Rating:
SELL
Grade

65.9

Top-Down

SectorNEGATIVE
IndustryPOSITIVE
SentimentNEGATIVE
FundamentalBUY

Revenue
Revenue Qtrly 03/31/2013 $38.67M
Revenue Qtrly Year Ago $59.86M
Revenue 1 Yr. Chg. -35.40%
Revenue 12 mo. trailing Latest $246.52M
Revenue 12 mo. trailing 3 Yrs. Ago $34.95M
Revenue 12 mo. trailing 3 Yr. Chg. 605.34%
Revenue Annual N/A N/A
Revenue 5 Yr. Gr. Rate 59.92%
 
Revenue Qtrly - 3 Yrs
Net Income
Net Income Qtrly 03/31/2013 -$2.79M
Net Income Qtrly Year Ago $46.54M
Net Income 1 Yr. Chg. -105.99%
Net Income 12 mo. trailing Latest $45.21M
Net Income 12 mo. trailing 3 Yrs. Ago -$58.68M
Net Income 12 mo. trailing 3 Yr. Chg. 177.05%
Net Income Annual N/A N/A
Net Income 5 Yr Growth Rate 35.12%
 
Net Income Qtrly - 3 Yrs
Cash Flow
Cash Flow Qtrly 03/31/2013 $21.64M
Cash Flow Qtrly Year Ago $26.91M
Cash Flow 1 Yr. Chg. -19.56%
Cash Flow 12 mo. tr. Latest $66.7M
Cash Flow 12 mo. tr. 3 Yrs. Ago -$43.96M
Cash Flow 12 mo. tr. 3 Yr. Chg. 251.71%
Free Cash Flow Qtrly 03/31/2013 $21.6M
Free Cash Flow 12 mo. tr. Latest $57.42M
Cash on Hand 03/31/2013 $163.38M
Free Cash Flow Qtrly - 3 Yrs
Balance Sheet
Total Debt $75M
Long Term Debt $75M
Total Assets $486.13M
Intangible Assets $235.5M
Book Value $284.26M
Tangible Book Value $48.76M
Stockholders' Equity $284.38M
Enterprise Value $400.84M
 
 
Total Debt Qtrly - 3 Yrs
Valuation
P/E Ratio 12 mo. trailing 11.81
Optimum P/E Ratio 15.00
Forward P/E Ratio -43.65
S&P 500 Forward P/E Ratio 15.20
Price to Book Ratio 1.72
Price to (tangible) Book Ratio 10.04
Price-to-Cash Flow Ratio 7.34
Price-to-Sales Ratio 2.01
Price-to-Sales Ratio Industry Avg. 518.05
Earnings Yield N/A
P/E Ratio Monthly - 1 Yr
Profitability
Return on Equity 12 mo. trailing 15.91%
Return on Equity 12 mo. tr. 1 Yr. Ago 34.38%
Total Invested Capital $359.38M
Return on Invested Capital 12 mo. tr. 15.09
Wght. Cost of Equity 7.81%
Wght. Cost of Debt N/A
Economic Value Added 7.28
 
 
 
ROE Qtrly - 3 Yrs
Financial Strength
Total Debt as % of Total Capital 20.87%
Long Term Debt as % of Total Capital 20.87%
Long Term Debt as % of Total Debt 100.00%
Total Debt / Cash Flow 12 mo. trailing 112.45
Interest Expense as % of Cash Flow Qtrly N/A
Cash on Hand 1 Yr. Chg. -12.31%
Capital Structure
Margins
Gross Margin Last Qtr. 76.34%
EBITDA Margin Last Qtr. -6.08%
Operating Margin Last Qtr. -12.40%
Operating Margin Industry avg. 13.81%
Operating Margin 12 mo. trailing 22.00%
Net Profit Margin Last Qtr. -7.21%
Margins
 
Start your 14 day FREE trial NOW!